Psychopharmacological Issues in Geriatrics

Psychopharmacological Issues in Geriatrics

Indexed in: EBSCO.

Demographic changes due to improved life expectancy and access to medical care has increased the number of people aged 65 years and beyond. This raises an important new challenge for healthcare ...
[view complete introduction]

US $
15

*(Excluding Mailing and Handling)



Mood Stabilizers

Pp. 155-185 (31)

Juan Medrano

Abstract

Mood stabilizers are those drugs used to treat and prevent acute episodes of bipolar disorder. The concept includes a host of agents: lithium, several anticonvulsants, and antipsychotics, notably, second-generation compounds. This chapter reviews the different drugs labelled as mood stabilizers and where available introduces some considerations on their use in old age. Given the lack of controlled trials enrolling elderly bipolar patients, most information derives from application to geriatric patients’ characteristics of those data obtained in studies with other age groups, and also from decades of clinical experience, especially with lithium.

Keywords:

Antidepressants, Aripiprazole, Bipolar disorder, Carbamazepine, Divalproex, First generation antipsychotics, Gabapentin, Haloperidol, Hypothyroidism, Johnson syndrome, Lamotrigine, Levetiracetam, Lithium, Lyell syndrome, Mood Stabilizer, Olanzapine, Oxcarbazepine, Quetiapine, Renal impairment, Risperidone, Second generation antipsychotics, Stevens, Topiramate, Valproate, Valproic acid.

Affiliation:

Ezkerraldea - Enkarterri Mental Health Community Services, Bizkaia`s Mental Health Network, Portugalete, Bizkaia/Vizcaya, Spain.